Background illustration for clinical trials search

Paid Clinical Trials Nashville

Discover 1,239 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of BI 3810944 in Patients With Advanced Cancer

for
Solid Tumours, Melanoma
Location: Nashville TN, Louisville KY
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07224425

Phase 1, Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

for
Hepatocellular Carcinoma (HCC)
Location: Nashville TN, Hackensack NJ, Mineola NY, Duarte CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07291076

Phase 1, Phase 2, Recruiting

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

for
Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR),
Location: Nashville TN, Indianapolis IN, Zion IL, Irving TX,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07403721

Phase 1, Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Nashville TN, Atlanta GA, Columbia MO, Salem VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221149

Phase 2, Phase 3, Recruiting

A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)

for
Squamous Non-small Cell Lung Cancer
Location: Nashville TN, St Louis MO, Ann Arbor MI, Cleveland OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07221474

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

for
Locally Advanced or Metastatic Malignant Solid Tumors
Location: Nashville TN, Fairfax VA, Celebration FL, Hackensack NJ,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07287995

Phase 1, Phase 2, Recruiting

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

for
Non-Small Cell Lung Cancer
Location: Nashville TN, Atlanta GA, St Louis MO, Columbus GA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07100080

Phase 2, Phase 3, Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for
Breast Neoplasms
Location: Nashville TN, Louisville KY, Germantown TN, O'Fallon IL,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Nashville TN, Birmingham AL, St Louis MO, Dayton OH,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase 3, Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

for
Acute Myeloid Leukemia (AML)
Location: Nashville TN, Lexington KY, Memphis TN, Columbus OH,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07007312

Phase 3, Recruiting

A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells

for
Long Term Safety Following GM T Cell Therapy
Location: Nashville TN
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06798298

Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Nashville TN, Hendersonville TN, Franklin TN, Smyrna TN,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT07028853

Phase 3, Recruiting

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

for
Breast Neoplasms
Location: Nashville TN, Indianapolis IN, Fairfax VA, Houston TX,
Sponsor: Eli Lilly and Company

Sex: Female

Age: 18+

Code: NCT07287098

Phase 2, Recruiting

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostatic Neoplasms
Location: Nashville TN, Chattanooga TN, Cincinnati OH, Greer SC,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07164443

Phase 3, Recruiting

Horizon Two: HR NDMM (MMRC-100)

for
High Risk Newly Diagnosed Multiple Myeloma
Location: Nashville TN, Atlanta GA, St Louis MO, Charlotte NC,
Sponsor: Multiple Myeloma Research Consortium

Sex: All

Age: 18+

Code: NCT07053436

Phase 2, Recruiting

Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Nashville TN, Peoria IL, Boston MA
Sponsor: Nerviano Medical Sciences

Sex: All

Age: 18+

Code: NCT06931626

Phase 1, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: Nashville TN, Atlanta GA, Edgewood KY, Wytheville VA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase 3, Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Chattanooga TN, Nashville TN, Louisville KY,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase 3, Recruiting

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma Refractory/ Relapsed,
Location: Nashville TN, St Louis MO, Buffalo NY, New York NY,
Sponsor: LTZ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07121946

Phase 1, Recruiting

Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

for
Ovarian Cancer
Location: Nashville TN, St Louis MO, Peoria IL, Houston TX,
Sponsor: Nerviano Medical Sciences

Sex: Female

Age: 18+

Code: NCT06930755

Phase 1, Recruiting